Michal Babič

Dr. Michal Babič


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Journal of Biomedical Nanotechnology
Verified
Journal Article
Closed access
BZBeata Anna Zasonska
Beata Anna Zasonska
NBNataliya Boiko
Nataliya Boiko
DHDaniel Horak
Daniel Horak
OKOlga Klyuchivska
Olga Klyuchivska
HMHana Mackova
Hana Mackova
Rostyslav S. StoikaRostyslav S. Stoika
Rostyslav S. Stoika
Gamma-Fe2O3 nanoparticles obtained by coprecipitation of Fe(II) and Fe(III) chlorides with a base and subsequent oxidation were coated with a shell of hydrophilic biocompatible poly(N,N-dimethylacrylamide) (PDMAAm). Various initiators were attached to the iron oxide surface to enable the use of the "grafting-from" approach for immobilization of PDMAAm. They included 2,2'-azobis(2-methylpropanimidamide) dihydrochloride (AMPA), 2,2'-azobis(N-hydroxy-2-methylpropanimidamide) dihydrochloride (ABHA) and 4-cyano-4-{[1-cyano-3-(N-hydroxycarbamoyl)-1-methylpropyl]azo}pentanoic acid (CCHPA). Engulfment of PDMAAm-coated y-Fe2O3 nanoparticles by murine J774.2 macrophages was investigated. Only some nanoparticles were engulfed by the macrophages. PDMAAm-AMPA-gamma-Fe2O3 and PDMAAm-ABHA-y-Fe2O3 nanoparticles were rapidly engulfed by the cells. In contrast, neat y-Fe2O3 and PDMAAm-CCHPA-gamma-Fe2O3 particles induced formation of transparent vacuoles indicating toxicity of the particles. Thus, PDMAAm-coated AMPA- and ABHA-gamma-Fe2O3 nanoparticles can be recommended as non-toxic labels for mammalian cells.

12 November 2020 in Journal of Polymer Research
Verified
Journal Article
Closed access
PDF file
MPMonika Paúrová
Monika Paúrová
IŠIvana Šeděnková
Ivana Šeděnková
JHJiřina Hromádková
Jiřina Hromádková
MBMichal Babič
Michal Babič

2 May 2011 in Chemistry of Materials
Verified
Journal Article
Closed access
DHDaniel Horak
Daniel Horak
TSTetiana Shagotova
Tetiana Shagotova
Natalia MitinaNatalia Mitina
Natalia Mitina
Miroslava TrchovaMiroslava Trchova
Miroslava Trchova
NBNataliya Boiko
Nataliya Boiko
AZAlexander Zaichenko
Alexander Zaichenko

21 September 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
PKPeter Kesa
Peter Kesa
MPMonika Paúrová
Monika Paúrová
MBMichal Babič
Michal Babič
THTomáš Heizer
Tomáš Heizer
PMPetr Matouš
Petr Matouš
VHVít Herynek
Vít Herynek
Photoacoustic imaging, an emerging modality, provides supplemental information to ultrasound imaging. We investigated the properties of polypyrrole nanoparticles, which considerably enhance contrast in photoacoustic images, in relation to the synthesis procedure and to their size. We prepared polypyrrole nanoparticles by water-based redox precipitation polymerization in the presence of ammonium persulphate (ratio nPy:nOxi 1:0.5, 1:1, 1:2, 1:3, 1:5) or iron(III) chloride (nPy:nOxi 1:2.3) acting as an oxidant. To stabilize growing nanoparticles, non-ionic polyvinylpyrrolidone was used. The nanoparticles were characterized and tested as a photoacoustic contrast agent in vitro on an imaging platform combining ultrasound and photoacoustic imaging. High photoacoustic signals were obtained with lower ratios of the oxidant (nPy:nAPS ≥ 1:2), which corresponded to higher number of conjugated bonds in the polymer. The increasing portion of oxidized structures probably shifted the absorption spectra towards shorter wavelengths. A strong photoacoustic signal dependence on the nanoparticle size was revealed; the signal linearly increased with particle surface. Coated nanoparticles were also tested in vivo on a mouse model. To conclude, polypyrrole nanoparticles represent a promising contrast agent for photoacoustic imaging. Variations in the preparation result in varying photoacoustic properties related to their structure and allow to optimize the nanoparticles for in vivo imaging.

1 August 2021 in European Polymer Journal
Verified
Journal Article
Closed access
MPMonika Paúrová
Monika Paúrová
OTOumayma Taboubi
Oumayma Taboubi
IŠIvana Šeděnková
Ivana Šeděnková
JHJiřina Hromádková
Jiřina Hromádková
PMPetr Matouš
Petr Matouš
MBMichal Babič
Michal Babič

19 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HCHana Charvátová
Hana Charvátová
ZPZdeněk Plichta
Zdeněk Plichta
JHJiřina Hromádková
Jiřina Hromádková
VHVít Herynek
Vít Herynek
MBMichal Babič
Michal Babič
Superparamagnetic iron oxide nanoparticles (SPION) with a “non-fouling” surface represent a versatile group of biocompatible nanomaterials valuable for medical diagnostics, including oncology. In our study we present a synthesis of novel maghemite (γ-Fe2O3) nanoparticles with positive and negative overall surface charge and their coating by copolymer P(HPMA-co-HAO) prepared by RAFT (reversible addition–fragmentation chain-transfer) copolymerization of N-(2-hydroxypropyl)methacrylamide (HPMA) with N-[2-(hydroxyamino)-2-oxo-ethyl]-2-methyl-prop-2-enamide (HAO). Coating was realized via hydroxamic acid groups of the HAO comonomer units with a strong affinity to maghemite. Dynamic light scattering (DLS) demonstrated high colloidal stability of the coated particles in a wide pH range, high ionic strength, and the presence of phosphate buffer (PBS) and serum albumin (BSE). Transmission electron microscopy (TEM) images show a narrow size distribution and spheroid shape. Alternative coatings were prepared by copolymerization of HPMA with methyl 2-(2-methylprop-2-enoylamino)acetate (MMA) and further post-polymerization modification with hydroxamic acid groups, carboxylic acid and primary-amino functionalities. Nevertheless, their colloidal stability was worse in comparison with P(HPMA-co-HAO). Additionally, P(HPMA-co-HAO)-coated nanoparticles were subjected to a bio-distribution study in mice. They were cleared from the blood stream by the liver relatively slowly, and their half-life in the liver depended on their charge; nevertheless, both cationic and anionic particles revealed a much shorter metabolic clearance rate than that of commercially available ferucarbotran.